|
시장보고서
상품코드
1504923
유도만능줄기세포(iPSC) 시장, 점유율, 규모, 동향, 산업 분석 리포트 : 파생 세포별, 워크플로우별, 용도별, 지역별, 부문별 예측(2024-2032년)Induced Pluripotent Stem Cell Market Share, Size, Trends, Industry Analysis Report, By Derived Cell; By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 유도만능줄기세포(iPSC) 세계 시장 규모는 2032년까지 43억 5,556만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학에 대한 상세 인사이트를 제시하고, 향후 시장 성장에 관한 분석을 제공하고 있습니다.
노인 인구 증가, 만성질환 증가, 연구개발의 발전이 iPSC 시장의 성장 확대에 기여하고 있습니다. 이러한 성장은 첨단 의약품 개발 및 시험에 관심이 있는 전 세계 제약회사로부터 많은 투자를 유치하여 전체 iPSC 시장의 성장에 기여하고 있습니다.
줄기세포의 전체 워크플로는 복잡하지만, iPSC 생산과 관련된 중요하고 복잡한 프로세스에는 제작, 초기화, 다양한 목적의 세포 유형으로의 분화 등 다양한 전문 지식과 리소스가 필요한 중요한 과정이 포함되어 있으며, 신규 시장 진출기업에게는 특별한 기회입니다. 필요합니다. 그러나 시판되는 iPSC 유래 세포를 구매하거나 프로그래밍을 아웃소싱할 수 있는 옵션이 있으므로 신규 시장 진출기업은 이 분야를 개척하고 성장에 기여할 수 있는 기회를 갖게 될 것입니다.
시장 진입을 위한 몇 가지 선택지가 있는 가운데, 리프로그래밍 및 자체 분화에 집중하거나, 시판 중인 제품 포트폴리오에서 iPSC 유래 세포 유형을 구매하거나, 제3공급자와 계약을 맺어 맞춤형 모델을 제작하는 등 몇 가지 추세가 관찰됩니다. 하는 등 몇 가지 추세를 관찰할 수 있습니다. 이러한 추세는 많은 질병 모델, 표현형 분석 및 독성 검사에 iPSC 기반 모델을 사용할 수 있는 가능성에 박차를 가하고 있습니다.
바이오의약품은 호르몬, 백신, 단클론 항체, 치료용 효소, 혈액 인자 등 미생물에서 유래한 의약품입니다. 이들 의약품은 특이성이 높아 맞춤형 의료 등 헬스케어에 새로운 길을 열어주고 있습니다. 이 접근법은 환자의 생리적, 생물학적, 유전적 구성에 따라 특정 생체 분자를 사용하여 다양한 질병과 증상을 치료합니다. 기존 의약품은 적용 범위가 제한적이고 생명공학 업계에는 기업이 많지 않아 세포 배양 기술의 성장에 박차를 가하고 있습니다.
iPSC 시장 보고서 하이라이트
2023년 세계 시장은 심근세포가 지배적인 부문으로 부상하며 괄목할 만한 성장을 이루었습니다. 이는 심장의 수축과 펌프 작용을 담당하는 심장의 특수 근육 세포인 심근세포가 치료적 응용 가능성으로 인해 큰 주목을 받고 있기 때문입니다.
재생의료 산업은 향후 수년간 상당한 성장률을 보일 것으로 예상됩니다. 재생의료는 부상이나 질병으로 고통받는 개인의 정상적인 기능을 회복하기 위해 조직과 장기를 복구, 대체, 재생하는 것을 목표로 하는 치료 기술을 포함합니다.
북미는 생물 의학 분야의 광범위한 조사와 기술 혁신으로 세계 시장을 독점하고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 유도만능줄기세포(iPSC) 시장 인사이트
- 워크플로우 스냅숏
- 유도만능줄기세포(iPSC) 시장 역학
- 촉진요인과 기회
- 신체 재건 수술과 조직공학의 수요 증가
- 백신 제조, 인공장기, 배지, 바이오의약품의 수요 증가
- 억제요인과 과제
- 동물에 관한 윤리적 우려
- 촉진요인과 기회
- PESTEL 분석
- 유도만능줄기세포(iPSC) 시장의 워크플로우 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 유도만능줄기세포(iPSC) 시장 : 파생 세포별
- 주요 조사 결과
- 서론
- 간세포
- 섬유아세포
- 신경세포
- 양막 세포
- 심근 세포
- 기타
제6장 세계의 유도만능줄기세포(iPSC) 시장 : 용도별
- 주요 조사 결과
- 서론
- 제조업
- 학술연구
- 의약품 개발과 발견
- 독성 스크리닝
- 재생의료
제7장 세계의 유도만능줄기세포(iPSC) 시장 : 워크플로우별
- 주요 조사 결과
- 서론
- 리프로그래밍
- 세포배양
- 세포 특성 평가/분석
- 엔지니어링
- 기타
제8장 세계의 유도만능줄기세포(iPSC) 시장 : 지역
- 주요 조사 결과
- 서론
- 유도만능줄기세포(iPSC) 시장 평가 : 지역, 2019-2032년
- 북미
- 북미 : 파생 세포별,2019-2032년
- 북미 : 워크플로우별, 2019-2032년
- 북미 : 용도별,2019-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 파생 셀별,2019-2032년
- 유럽 : 워크플로우별,2019-2032년
- 유럽 : 용도별,2019-2032년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 아시아태평양
- 아시아태평양 : 파생 셀별,2019-2032년
- 아시아태평양 : 워크플로우별,2019-2032년
- 아시아태평양 : 용도별,2019-2032년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 중동 및 아프리카
- 중동 및 아프리카 : 파생 셀별,2019-2032년
- 중동 및 아프리카 : 워크플로우별,2019-2032년
- 중동 및 아프리카 : 용도별,2019-2032년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 라틴아메리카
- 라틴아메리카 : 파생 셀별, 2019-2032년
- 라틴아메리카 : 워크플로우별,2019-2032년
- 라틴아메리카 : 용도별,2019-2032년
- 멕시코
- 브라질
- 아르헨티나
제9장 경쟁 구도
- 확대와 인수의 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Astellas Pharma Inc
- Axol Bioscience Ltd
- Cynata Therapeutics Limited
- Fate Therapeutics
- FUJIFILM Holdings Corporation(Cellular Dynamics)
- Ncardia
- REPROCELL Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- ViaCyte, Inc
The global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report "iPSC Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing elderly population, rising cases of chronic diseases, and advancements in research and development are contributing to the increasing growth of the iPSC market. This growth is attracting significant investments from pharmaceutical companies worldwide, who are interested in advanced drug development and testing, and is thereby catering to the overall growth of the iPSC market.
The overall stem cell workflow, although complex, presents a unique opportunity for new entrants in the production of iPSC. Some of the critical and complex processes involved in the production of iPSC include generation, reprogramming, and differentiation into various desired cell types, which require both expertise and resources. However, with the option of commercial iPSC-derived cell purchase or outsourcing programming, new entrants are encouraged to explore this field and contribute to its growth.
With several market entry options available, several trends are observed, such as concentrated efforts on reprogramming and in-house differentiation, purchase of iPSC-derived cell types from off-the-shelf product portfolios, or entering into agreements with third-party purveyors to produce customized models. This trend has spurred a range of possibilities that will feature iPSC-based models for a host of disease models, phenotypic assays, and toxicology testing.
Biopharmaceuticals are drugs that are derived from microbiological sources such as hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, and so on. These drugs are highly specific and have opened up new avenues in healthcare, such as personalized medicine. This approach involves treating various diseases or conditions using specific biomolecules depending on the patient's physiological, biological, and genetic makeup. As conventional pharmaceuticals have limited applicability and there are few players in the biotechnology industry, the growth of cell culture technology has been fueled.
iPSC Market Report Highlights
In 2023, the global market witnessed significant growth, with cardiomyocytes emerging as the dominant segment. This is because cardiomyocytes, specialized muscle cells in the heart responsible for its contraction and pumping action, have gained significant attention due to their potential for therapeutic applications.
The regenerative medicine industry is projected to experience a substantial growth rate in the upcoming years. Regenerative medicine involves therapeutic techniques that target the repair, replacement, or regeneration of tissues or organs in order to restore normal function in individuals who are suffering from injury or disease.
The North American region dominated the global market, owing to its extensive research and innovation in the field of biomedical science.
The global key market players include Astellas Pharma Inc., Axol Bioscience Ltd., Cynata Therapeutics Limited, Fate Therapeutics, FUJIFILM Holdings Corporation (Cellular Dynamics), Ncardia, REPROCELL Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., ViaCyte, Inc, etc.
Polaris Market Research has segmented the iPSC market report based on derived cell, workflow, application, and region:
iPSC, Derived Cell Outlook (Revenue - USD Million, 2019 - 2032)
- Hepatocytes
- Fibroblasts
- Neural Cells
- Excitatory Neurons
- Inhibitory Neurons
- Amniotic Cells
- Cardiomyocytes
- Others
iPSC, Workflow Outlook (Revenue - USD Million, 2019 - 2032)
- Reprogramming
- Cell Culture
- Cell Characterization / Analysis
- Engineering
- Others
iPSC, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Manufacturing
- Academic Research
- Drug Development & Discovery
- Toxicity Screening
- Regenerative Medicine
iPSC, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Austria
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Induced Pluripotent Stem Cell (iPSC) Market Insights
- 4.1. Induced Pluripotent Stem Cell (iPSC) Market - Workflow Snapshot
- 4.2. Induced Pluripotent Stem Cell (iPSC) Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing demand for body reconstruction procedures and tissue engineering
- 4.2.1.2. Rising Demand for Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
- 4.2.2. Restraints and Challenges
- 4.2.2.1 Ethical Concerns Pertaining to Animals
- 4.2.3 Porter's Five Forces Analysis
- 4.2.3.1. Bargaining Power of Suppliers (Moderate)
- 4.2.3.2. Threats of New Entrants: (Low)
- 4.2.3.3. Bargaining Power of Buyers (Moderate)
- 4.2.3.4. Threat of Substitute (Moderate)
- 4.2.3.5 Rivalry among existing firms (High)
- 4.2.1. Drivers and Opportunities
- 4.3. PESTEL Analysis
- 4.4. Induced Pluripotent Stem Cell (iPSC) Market Workflow Trends
- 4.5. Value Chain Analysis
- 4.6. COVID-19 Impact Analysis
5. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 5.3. Hepatocytes
- 5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Hepatocytes, by Region, 2019-2032 (USD Million)
- 5.4. Fibroblasts
- 5.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Fibroblasts, by Region, 2019-2032 (USD Million)
- 5.5. Neural Cells
- 5.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Neural Cells, by Region, 2019-2032 (USD Million)
- 5.5.2. Excitatory Neurons
- 5.5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Excitatory Neurons, by Region, 2019-2032 (USD Million)
- 5.5.3. Inhibitory Neurons
- 5.5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Inhibitory Neurons, by Region, 2019-2032 (USD Million)
- 5.6. Amniotic Cells
- 5.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Amniotic Cells, by Region, 2019-2032 (USD Million)
- 5.7. Cardiomyocytes
- 5.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cardiomyocytes, by Region, 2019-2032 (USD Million)
- 5.8. Others
- 5.8.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 6.3. Manufacturing
- 6.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Manufacturing, by Region, 2019-2032 (USD Million)
- 6.4. Academic Research
- 6.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Academic Research, by Region, 2019-2032 (USD Million)
- 6.5. Drug Development & Discovery
- 6.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Drug Development & Discovery, by Region, 2019-2032 (USD Million)
- 6.6. Toxicity Screening
- 6.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Toxicity Screening, by Region, 2019-2032 (USD Million)
- 6.7. Regenerative Medicine
- 6.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)
7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 7.3. Reprogramming
- 7.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Reprogramming, By Region, 2019-2032 (USD Million)
- 7.4. Cell Culture
- 7.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Culture, By Region, 2019-2032 (USD Million)
- 7.5. Cell Characterization / Analysis
- 7.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Characterization / Analysis, By Region, 2019-2032 (USD Million)
- 7.6. Engineering
- 7.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Engineering, By Region, 2019-2032 (USD Million)
- 7.7. Others
- 7.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Induced Pluripotent Stem Cell (iPSC) Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Induced Pluripotent Stem Cell (iPSC) Market - North America
- 8.3.1. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.3.2. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.3.3. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.3.4. Induced Pluripotent Stem Cell (iPSC) Market - U.S.
- 8.3.4.1. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.3.5. Induced Pluripotent Stem Cell (iPSC) Market - Canada
- 8.3.5.1. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4. Induced Pluripotent Stem Cell (iPSC) Market - Europe
- 8.4.1. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.2. Europe.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.3. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.4. Induced Pluripotent Stem Cell (iPSC) Market - UK
- 8.4.4.1. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.4.3. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.5. Induced Pluripotent Stem Cell (iPSC) Market - France
- 8.4.5.1. France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.5.2. France.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.5.3. France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.6. Induced Pluripotent Stem Cell (iPSC) Market - Germany
- 8.4.6.1. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.7. Induced Pluripotent Stem Cell (iPSC) Market - Italy
- 8.4.7.1. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.8. Induced Pluripotent Stem Cell (iPSC) Market - Spain
- 8.4.8.1. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.9. Induced Pluripotent Stem Cell (iPSC) Market - Netherlands
- 8.4.9.1. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.10. Induced Pluripotent Stem Cell (iPSC) Market - Russia
- 8.4.10.1. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5. Induced Pluripotent Stem Cell (iPSC) Market - Asia Pacific
- 8.5.1. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.4. Induced Pluripotent Stem Cell (iPSC) Market - China
- 8.5.4.1. China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.4.2. China.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.4.3. China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.5. Induced Pluripotent Stem Cell (iPSC) Market - India
- 8.5.5.1. India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.5.2. India.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.5.3. India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.6. Induced Pluripotent Stem Cell (iPSC) Market - Malaysia
- 8.5.6.1. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.7. Induced Pluripotent Stem Cell (iPSC) Market - Japan
- 8.5.7.1. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.8. Induced Pluripotent Stem Cell (iPSC) Market - Indonesia
- 8.5.8.1. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.9. Induced Pluripotent Stem Cell (iPSC) Market - South Korea
- 8.5.9.1. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6. Induced Pluripotent Stem Cell (iPSC) Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.4. Induced Pluripotent Stem Cell (iPSC) Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.5. Induced Pluripotent Stem Cell (iPSC) Market - UAE
- 8.6.5.1. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.6. Induced Pluripotent Stem Cell (iPSC) Market - Israel
- 8.6.6.1. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.7. Induced Pluripotent Stem Cell (iPSC) Market - South Africa
- 8.6.7.1. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7. Induced Pluripotent Stem Cell (iPSC) Market - Latin America
- 8.7.1. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.7.3. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7.4. Induced Pluripotent Stem Cell (iPSC) Market - Mexico
- 8.7.4.1. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7.5. Induced Pluripotent Stem Cell (iPSC) Market - Brazil
- 8.7.5.1. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7.6. Induced Pluripotent Stem Cell (iPSC) Market - Argentina
- 8.7.6.1. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Astellas Pharma Inc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Axol Bioscience Ltd
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Cynata Therapeutics Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Fate Therapeutics
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. FUJIFILM Holdings Corporation (Cellular Dynamics)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Ncardia
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. REPROCELL Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Takara Bio Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Thermo Fisher Scientific Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. ViaCyte, Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
